[Hot Topics] III. Antithrombotics

April 29, 2022 / 12:50 PM ~ 2:35 PM 📌 Channel 1

Moderator(s): David Joel Cohen, Duk-Woo Park
Panelist(s): Junya Ako, Yun-Dai Chen, Joo-Yong Hahn, Kyung Woo Park, Stefanie Schupke

Tailored Antithrombotic Strategy
- Guided vs. Potent P2Y12 Inhibitor Therapy: Updated Evidence [Dominick J. Angiolillo]
- Tools for Guided Antithrombotic Strategies: Genotyping, Platelet Function, and Others [Tullio Palmerini]
- Optimal Antithrombotic Therapy After PCI in Asia (Japan): Why We Are Going Our Own Way? [Takeshi Kimura]
- Interactive Discussion With Audience Q&A

DAPT Duration Issues
- DAPT Study vs. Contemporary Trials: How Can We Reduce the Knowledge Gap? [Robert W. Yeh]
- DAPT Duration and NOAC Selection in the Afib-PCI Patient [Renato D. Lopes]
- Long-Term Antithrombotic Strategy in PCI and AF Patients: Insights From the AFIRE Trial [Satoshi Yasuda]
- Interactive Discussion With Audience Q&A
Share this Post: